Sees FY25 revenue $2.68B-$2.74B, consensus $2.7B
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho receives FDA 510(k) clearance for VITROS hs Troponin I Assay
- Is QDEL a Buy, Before Earnings?
- QuidelOrtho Hold Rating: Impact of Debt Refinancing and Chinese Market Risks
- QuidelOrtho downgraded to Neutral from Buy at Citi
- QuidelOrtho announces availability of QUICKVUE Influenza + SARS Test